High glutamine levels suppress immune response in head and neck cancer tumors

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup